题名 | Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancer. |
链接 | http://journals.lww.com/jto/pages/articleviewer.aspx?year=2012&issue=02000&article=00008&type=abstract |
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |